Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial
Antill, Yoland, Kok, Peey-Sei, Robledo, Kristy, Yip, Sonia, Cummins, Michelle, Smith, Deborah, Spurdle, Amanda, Barnes, Elizabeth, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Andrews, John, Stockler, Martin R, Mileshkin, Linda
Published in Journal for immunotherapy of cancer (01.06.2021)
Published in Journal for immunotherapy of cancer (01.06.2021)
Get full text
Journal Article
Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges
Lefkovits, Yael R, Heriot, Natalie, Sporik, Alice, Perera, Sharnel, Friedlander, Michael, Dixon, Cyril, Cohen, Paul A, Lee, Yeh Chen, Hyde, Simon, Richardson, Gary, Webb, Penelope, Rome, Robert, King, Madeleine, Zalcberg, John, Schofield, Penelope
Published in BMC health services research (08.07.2024)
Published in BMC health services research (08.07.2024)
Get full text
Journal Article
Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
Hayes, Sandra, Obermair, Andreas, Mileshkin, Linda, Davis, Alison, Gordon, Louisa G, Eakin, Elizabeth, Janda, Monika, Beesley, Vanessa L, Barnes, Elizabeth H, Spence, Rosalind Renee, Sandler, Carolina, Jones, Tamara, Vagenas, Dimitrios, Webb, Penny, Andrews, John, Brand, Alison, Lee, Yeh Chen, Friedlander, Michael, Pumpa, Kate, O’Neille, Helene, Williams, Merran, Stockler, Martin, Cattley, Trudi, Nicklin, James, Garrett, Andrea, Singh, Piksi, Goh, Jeff, Shannon, Catherine, Perrin, Lewis, Alkhateeb, Amasy, Sommeijer, Dirkje, Creed, Melissa, Rye, Sheree, McDonald, Nicole
Published in BMJ open (13.04.2023)
Published in BMJ open (13.04.2023)
Get full text
Journal Article
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)
Smith, Deborah, Robledo, Kristy P, Yip, Sonia, Cummins, Michelle M, Kok, Peey-Sei, Lee, Yeh Chen, Friedlander, Michael, Baron-Hay, Sally, Shannon, Catherine, Coward, Jermaine, Beale, Philip, Goss, Geraldine, Meniawy, Tarek, Lombard, Janine, Spurdle, Amanda B, Andrews, John, Stockler, Martin R, Mileshkin, Linda, Antill, Yoland
Published in Cancers (30.12.2022)
Published in Cancers (30.12.2022)
Get full text
Journal Article
Favorable Response to Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients with High Serum Fucosyl-Agalactosyl IgG
Ho, Cheng-Hsun, Tsai, Hung-Wen, Lee, Chen-Yeh, Huang, Li-Juan, Chien, Rong-Nan, Wu, I-Chin, Chiu, Yen-Cheng, Liu, Wen-Chun, Cheng, Pin-Nan, Chang, Ting-Tsung, Chen, Shu-Hui
Published in Scientific reports (16.05.2017)
Published in Scientific reports (16.05.2017)
Get full text
Journal Article
Haemophilus influenzae Type b Vaccine Failure in Children Is Associated with Inadequate Production of High-Quality Antibody
Lee, Yeh Chen, Kelly, Dominic F., Yu, Ly-Mee, Slack, Mary P. E., Booy, Robert, Heath, Paul T., Siegrist, Claire-Anne, Moxon, Richard E., Pollard, Andrew J.
Published in Clinical infectious diseases (15.01.2008)
Published in Clinical infectious diseases (15.01.2008)
Get full text
Journal Article
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Lheureux, Stephanie, Oaknin, Ana, Garg, Swati, Bruce, Jeffrey P, Madariaga, Ainhoa, Dhani, Neesha C, Bowering, Valerie, White, Justin, Accardi, Sarah, Tan, Qian, Braunstein, Marsela, Karakasis, Katherine, Cirlan, Iulia, Pedersen, Stephanie, Li, Tiantiam, Fariñas-Madrid, Lorena, Lee, Yeh Chen, Liu, Zhihui Amy, Pugh, Trevor J, Oza, Amit M
Published in Clinical cancer research (15.08.2020)
Published in Clinical cancer research (15.08.2020)
Get full text
Journal Article
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
Mileshkin, Linda R, Moore, Kathleen N, Barnes, Elizabeth H, Gebski, Val, Narayan, Kailash, King, Madeleine T, Bradshaw, Nathan, Lee, Yeh Chen, Diamante, Katrina, Fyles, Anthony W, Small, William, Gaffney, David K, Khaw, Pearly, Brooks, Susan, Thompson, J Spencer, Huh, Warner K, Mathews, Cara A, Buck, Martin, Suder, Aneta, Lad, Thomas E, Barani, Igor J, Holschneider, Christine H, Van Dyk, Sylvia, Quinn, Michael, Rischin, Danny, Monk, Bradley J, Stockler, Martin R
Published in The lancet oncology (01.05.2023)
Published in The lancet oncology (01.05.2023)
Get full text
Journal Article
Adjuvant chemotherapy for locally advanced cervical cancer – Authors’ reply
Mileshkin, Linda R, Narayan, Kailash, Gaffney, David K, Barnes, Elizabeth H, Lee, Yeh Chen, Monk, Bradley J, Stockler, Martin R
Published in The lancet oncology (01.07.2023)
Published in The lancet oncology (01.07.2023)
Get full text
Journal Article
PR004/#458 Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer
Werner, Bonnita, Powell, Elyse, Duggan, Jennifer, Lee, Yeh Chen, Athavale, Ramanand, Dean, Michael, Warton, Kristina, Ford, Caroline
Published in International journal of gynecological cancer (07.11.2023)
Published in International journal of gynecological cancer (07.11.2023)
Get full text
Journal Article
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients
Sivakumaran, Tharani, Krasovitsky, Michael, Freimund, Alison, Lee, Yeh Chen, Webber, Kate, So, Jane, Norris, Christie, Friedlander, Michael, Mileshkin, Linda, Au-Yeung, George
Published in International journal of gynecological cancer (01.07.2022)
Published in International journal of gynecological cancer (01.07.2022)
Get full text
Journal Article
PO003/#269 Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification
Au-Yeung, George, Bressel, Mathias, Prall, Owen, Opar, Petra, Andrews, John, Mongta, Sally, Lee, Yeh Chen, Gao, Bo, Meniawy, Tarek, Baron-Hay, Sally, Black, Allison, Kichenadasse, Ganessan, Ananda, Sumitra, Fox, Peter, Bowtell, David, Mileshkin, Linda
Published in International journal of gynecological cancer (07.11.2023)
Published in International journal of gynecological cancer (07.11.2023)
Get full text
Journal Article
713 The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601)
Buchanan, Daniel, Joo, Ji-Hoon Eric, Mahmood, Khalid, Georgeson, Peter, Walker, Rommy, Robledo, Kristy, Cummins, Michelle, Spurdle, Amanda B, Smith, Deborah, Clendenning, Mark, Como, Julia, Preston, Susan, Yip, Sonia, Andrews, John, Kok, Peey-Sei, Lee, Yeh Chen, Stockler, Martin, Mileshkin, Linda, Antill, Yoland
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
546 AtTEnd/ENGOT-EN7: phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma
Colombo, Nicoletta, Harano, Kenichi, Hudson, Emma, Galli, Francesca, Antill, Yoland, Choi, Chel Hun, Rabaglio, Manuela, Marmé, Frederik, Petru, Edgar, Lai, Chyong-Huey, Biagioli, Elena, Fariñas-Madrid, Lorena, Takehara, Kazuhiro, Allan, Karen, Lee, Yeh Chen, Piovano, Elisa, Zamagni, Claudio, Tasca, Giulia, Ferrero, Annamaria, Barretina-Ginesta, Maria-Pilar
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
523 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of AtTEnd/ENGOT-EN7 trial
Nishio, Shin, Pardo, Beatriz, Hudson, Emma, Rulli, Eliana, Antill, Yoland, Lee, Chulmin, Rabaglio, Manuela, Heitz, Florian, Leitner, Katharina, Lai, Chyong-Huey, Uggeri, Sara, Manso, Luis, Harano, Kenichi, Allan, Karen, Lee, Yeh Chen, Tognon, Germana, Canova, Stefania, Petrella, Maria Cristina, Gadducci, Angiolo, Colombo, Nicoletta
Published in International journal of gynecological cancer (10.03.2024)
Published in International journal of gynecological cancer (10.03.2024)
Get full text
Journal Article
A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers
Gonzalez-Ochoa, Eduardo, Milosevic, Michael, Corr, Bradley, Abbruzzese, James L, Girda, Eugenia, Miller, Rachel W, Croke, Jennifer, Mackay, Helen, Lee, Yeh Chen, Bowering, Valerie, Ramsahai, Janelle, Wang, Lisa, D'Souza, April, Kunos, Charles A, Oza, Amit M, Lheureux, Stephanie
Published in International journal of gynecological cancer (01.08.2023)
Published in International journal of gynecological cancer (01.08.2023)
Get full text
Journal Article
TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer
Richardson, Debra, Perez Fidalgo, Jose Alejandro, Gonzalez-Martin, Antonio, Oaknin, Ana, Hamilton, Erika, Hays, John, Pothuri, Bhavana, Papadopoulos, Kyriakos, Taylor, Sara, Huang, Marilyn, Lee, Yeh-Chen, Krivak, Thomas, Moreno-Garcia, Victor, Calvo, Emiliano, Randall, Leslie, Starks, David, Ross, Malcom, Duska, Linda, Gao, Bo, Poka, Robert, Putiri, Emily, Barrett, Jamie, Demars, Leslie, Concin, Nicole
Published in International journal of gynecological cancer (04.12.2022)
Published in International journal of gynecological cancer (04.12.2022)
Get full text
Journal Article
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study
Lee, Yeh Chen, King, Madeleine T, O'Connell, Rachel L, Lanceley, Anne, Joly, Florence, Hilpert, Felix, Davis, Alison, Roncolato, Felicia T, Okamoto, Aikou, Bryce, Jane, Donnellan, Paul, Oza, Amit M, Avall-Lundqvist, Elisabeth, Berek, Jonathan S, Ledermann, Jonathan A, Berton, Dominique, Sehouli, Jalid, Feeney, Amanda, Kaminsky, Marie-Christine, Diamante, Katrina, Stockler, Martin R, Friedlander, Michael L
Published in International journal of gynecological cancer (01.06.2022)
Published in International journal of gynecological cancer (01.06.2022)
Get full text
Journal Article
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer
Cohen, Paul A, Webb, Penelope M, King, Madeleine, Obermair, Andreas, Gebski, Val, Butow, Phyllis, Morton, Rachael, Lawson, Wanda, Yates, Patsy, Campbell, Rachel, Meniawy, Tarek, McMullen, Michelle, Dean, Andrew, Goh, Jeffrey, McNally, Orla, Mileshkin, Linda, Beale, Philip, Beach, Rhonda, Hill, Jane, Dixon, Cyril, Hegarty, Sue, Codde, Jim, Ives, Angela, Lee, Yeh Chen, Brand, Alison, Mellon, Anne, Bilic, Sanela, Black, Isobel, Jeffares, Stephanie, Friedlander, Michael
Published in International journal of gynecological cancer (01.04.2022)
Published in International journal of gynecological cancer (01.04.2022)
Get full text
Journal Article